ABEMACICLIB
Clinical trials for ABEMACICLIB explained in plain language.
Never miss a new study
Get alerted when new ABEMACICLIB trials appear
Sign up with your email to follow new studies for ABEMACICLIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study to track why some breast cancer patients stop taking Life-Saving pills
Knowledge-focused Not yet recruitingThis study will follow 81 people with early-stage, hormone-positive breast cancer who are at high risk of the cancer coming back. Researchers want to see how often patients stop taking their prescribed CDK4/6 inhibitor pills (abemaciclib or ribociclib) before the full treatment c…
Matched conditions: ABEMACICLIB
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated May 26, 2026 05:04 UTC
-
Blood test may predict severe diarrhea in breast cancer drug
Knowledge-focused Not yet recruitingThis study looks at how the amount of abemaciclib in the blood is linked to severe diarrhea in people with hormone receptor-positive breast cancer. About 235 women with early-stage, high-risk breast cancer will have their blood levels measured during treatment. The goal is to cre…
Matched conditions: ABEMACICLIB
Phase: PHASE4 • Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC